User login
Federal Practitioner is inviting VA, DoD, and PHS health care providers and researchers to contribute to a future special issue on hematology topics, including myelomas, lymphomas, leukemias, and other bloodborne dieases.
Interested authors should submit a brief 2 to 3 sentence abstract to [email protected]. Federal Practitioner welcomes case studies, literature reviews, original research, program profiles, guest editorials, and other evidence-based articles. The updated and complete submission guidelines, including details about the style and format, can be found here:
http://www.mdedge.com/fedprac/page/submission-guidelines
Federal Practitioner uses Editorial Manager , a web-based manuscript submission and review system. All manuscripts must be submitted through this system.
All manuscripts submitted to Federal Practitioner for both special and regular issues will be subject to peer review. Peer reviews are conducted in a double-blind fashion, and the reviewers are asked to comment on the manuscript’s importance, accuracy, relevance, clarity, timeliness, balance, and reference citation. Final decisions on all submitted manuscripts are made by the Editor-in-Chief (or, in the event of a potential conflict of interest, a designated surrogate from the journal’s Editorial Advisory Association).
Federal Practitioner is inviting VA, DoD, and PHS health care providers and researchers to contribute to a future special issue on hematology topics, including myelomas, lymphomas, leukemias, and other bloodborne dieases.
Interested authors should submit a brief 2 to 3 sentence abstract to [email protected]. Federal Practitioner welcomes case studies, literature reviews, original research, program profiles, guest editorials, and other evidence-based articles. The updated and complete submission guidelines, including details about the style and format, can be found here:
http://www.mdedge.com/fedprac/page/submission-guidelines
Federal Practitioner uses Editorial Manager , a web-based manuscript submission and review system. All manuscripts must be submitted through this system.
All manuscripts submitted to Federal Practitioner for both special and regular issues will be subject to peer review. Peer reviews are conducted in a double-blind fashion, and the reviewers are asked to comment on the manuscript’s importance, accuracy, relevance, clarity, timeliness, balance, and reference citation. Final decisions on all submitted manuscripts are made by the Editor-in-Chief (or, in the event of a potential conflict of interest, a designated surrogate from the journal’s Editorial Advisory Association).
Federal Practitioner is inviting VA, DoD, and PHS health care providers and researchers to contribute to a future special issue on hematology topics, including myelomas, lymphomas, leukemias, and other bloodborne dieases.
Interested authors should submit a brief 2 to 3 sentence abstract to [email protected]. Federal Practitioner welcomes case studies, literature reviews, original research, program profiles, guest editorials, and other evidence-based articles. The updated and complete submission guidelines, including details about the style and format, can be found here:
http://www.mdedge.com/fedprac/page/submission-guidelines
Federal Practitioner uses Editorial Manager , a web-based manuscript submission and review system. All manuscripts must be submitted through this system.
All manuscripts submitted to Federal Practitioner for both special and regular issues will be subject to peer review. Peer reviews are conducted in a double-blind fashion, and the reviewers are asked to comment on the manuscript’s importance, accuracy, relevance, clarity, timeliness, balance, and reference citation. Final decisions on all submitted manuscripts are made by the Editor-in-Chief (or, in the event of a potential conflict of interest, a designated surrogate from the journal’s Editorial Advisory Association).